INFLAMMATION, INFECTION, OR BOTH? ROOT CAUSES OF ENDOMETRITIS
are cytoplasmatic fragments of the megakaryocytes that carry numerous growth factors (e.g., vascular en- dothelial growth factor, transforming growth factor b), cytokines (e.g., TNF-a and CLX8), and antimicrobial peptides (e.g., platelet basic protein, RANTES, thymo- sin beta-4). These growth factors, cytokines, and anti- microbial peptides are released after platelet activation and act in an anti-inflammatory matter. Even though the mechanisms of PRP to mitigate inflammation are not yet well elucidated, the suppression of inflamma- torymarkers (e.g., COX-2,metalloproteinase-3, TNF-a, IL1b, IL6, CXCL8) has been described in several in vitro studies,16–18 as well as in mares treated with intrauterine infusion of PRP.9,13 In addition, PRP has demonstrated antimicrobial activity against microor- ganisms-causing endometritis19–21 and reduced post- breeding uterine infections in mares susceptible to endometritis.9 Many protocols can be used to produce PRP.22 Auto-
mated commercial and manual protocols have been described. These protocols differ in time to prepare, costs, practicality, volume of blood needed, and materi- als required for processing. Therefore, the protocol used will depend on the practitioner’s choice. In addition, variations of PRP quality can be observed between practitioners, methods, and animals. Although not all theprotocols availabletoproducePRP will beover- viewed in this study, the authors will comment on the most commonly used and proposed therapies in mares. Additional protocols can be reviewed in other manu- scripts.22,23 In addition, a commercially available ly- ophilized PRPa has been recently described for use in broodmare practice.24 Many clinicians have employed protocols using
vacutainer tubes or blood transfusion bags to produce PRP with good results for intrauterine infusion in mares. The vacutainer tubes protocol is themost com- monly used in the field. Using this protocol, blood is collected in 4.5mL vacutainer tubes containing 3.2% sodiumcitrate to produce PRP. Blood tubes are centri-
fuged at 120g for 10min. After centrifugation, the top third layer of the plasma is discarded, while the remaining plasma adjacent to the buffy coat is recov- ered as PRP (Fig. 1). The amount of blood collected to produce PRP by this method depends on the practi- tioner’s choice or the number of tubes placed in the centrifuge. To produce PRP using a blood transfusion bag, blood
is collected in a 450mL blood transfusion bag contain- ing 63mL of citrate-phosphate-dextrose solution with adenine as an anticoagulant (CPD-A). Four hundred milliliters of whole blood are split into eight 50-mL
tubes and centrifuged at 400g for 15min. After the first centrifugation, the plasma fraction is recovered and transferred into 15-mL conical tubes. This fraction
is submitted to centrifugation at 1000g for 10min. After the second centrifugation, 2.5mL of plasma at the bottom of each tube is preserved as PRP (Fig. 1). This method produces around 40 to 50mL of PRP for intrauterine infusion.
Practitioners have recently described another proto-
col that involves harvesting blood in a 60mL syringe prefilled with 7mL of CPD-A. The mixed-blood is transferred to a 50-mL falcon tube and centrifuged at
400g for 15min. After centrifugation, the whole plasma fraction (;30mL) is used for intrauterine infu- sion (Fig. 1). Many different protocols to obtain PRP have been used to treat mares with uterine problems. The number of treatments, the time that therapy was implemented, and the volume of PRP used for intrauterine infusion varies between studies.9,11–15,24 Independent of these differences, PRP therapy was able to reduce uterine inflammatory markers and improve the fertility rates ofmares in all reports.9,11–15,24 Results of PRP therapy in mares are highlighted in Table 1. In one of the authors’ studies,9 mares received four
uterine infusions of PRP (Fig. 2). In this study, the treatments were performed 48 and 24 h before and six and 24 h after breeding. The authors observed a sig- nificant benefit of those treatments in mitigating endometrial inflammation and uterine infections. However, implementing four treatments can be timing-consuming and expensive. Therefore, some practitioners have chosen only one or two treat- ments in a cycle to employ PRP therapy, as reported in other studies.11–15 In the author's experience, the best time to infuse PRP in mares to improve the uterine environment, mitigate post-breeding inflam- mation, and increase the chances of a mare becom- ing pregnant are 24 h before and 4-6 h after breeding. Practitioners can modify the protocol to best fit their practice.
3. Platelet Lysate
Platelet lysate (PL) is derived from freeze-thawing PRP. The PL contains all growth factors and cyto- kines released by the platelets after activation.25,26 Platelets are activated during cryopreservation, and the bioactive molecules released during this process are preserved in the PL.25,26 An advantage of PL com- pared to PRP is that this platelet-derived product can be frozen and stored long-term, making it available for immediate patient use. The processing of PL is simple. After PRP is obtained, it is diluted with platelet-poor plasma (PPP)
obtained during the processing protocol to bring a final volume of 10 to 20mL. Thereafter, the PRP alone
or the PRP+PPP should be frozen at 80°C. The freezing process will cause platelet disruption/activa- tion, and the PL containing platelet-released growth factors will be obtained.27 PL canbe frozenstored until needed. Before intrauterine infusion, PL must be at room temperature (20-25°C). Of interest, this therapy has been recently implemented to treat horses with osteoarthritis injuries.28,29 In a recent report, PL reduced PMN counts, intrauterine fluid accumulation, and edema score of mares susceptible to endometritis after breeding.30 Results of mares treatedwith PL are highlighted in Table 1.
AAEP PROCEEDINGS / Vol. 68 / 2022 47
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196 |
Page 197 |
Page 198 |
Page 199 |
Page 200 |
Page 201 |
Page 202 |
Page 203 |
Page 204 |
Page 205 |
Page 206 |
Page 207 |
Page 208 |
Page 209 |
Page 210 |
Page 211 |
Page 212 |
Page 213 |
Page 214 |
Page 215 |
Page 216 |
Page 217 |
Page 218 |
Page 219 |
Page 220 |
Page 221 |
Page 222 |
Page 223 |
Page 224 |
Page 225 |
Page 226 |
Page 227 |
Page 228 |
Page 229 |
Page 230 |
Page 231 |
Page 232 |
Page 233 |
Page 234 |
Page 235 |
Page 236 |
Page 237 |
Page 238 |
Page 239 |
Page 240 |
Page 241 |
Page 242 |
Page 243 |
Page 244 |
Page 245 |
Page 246 |
Page 247 |
Page 248 |
Page 249 |
Page 250 |
Page 251 |
Page 252 |
Page 253 |
Page 254 |
Page 255 |
Page 256 |
Page 257 |
Page 258 |
Page 259 |
Page 260 |
Page 261 |
Page 262 |
Page 263 |
Page 264 |
Page 265 |
Page 266 |
Page 267 |
Page 268 |
Page 269 |
Page 270 |
Page 271 |
Page 272 |
Page 273 |
Page 274 |
Page 275 |
Page 276 |
Page 277 |
Page 278 |
Page 279 |
Page 280 |
Page 281 |
Page 282 |
Page 283 |
Page 284 |
Page 285 |
Page 286 |
Page 287 |
Page 288 |
Page 289 |
Page 290 |
Page 291 |
Page 292 |
Page 293 |
Page 294 |
Page 295 |
Page 296 |
Page 297 |
Page 298 |
Page 299 |
Page 300 |
Page 301 |
Page 302 |
Page 303 |
Page 304 |
Page 305 |
Page 306 |
Page 307 |
Page 308 |
Page 309 |
Page 310 |
Page 311 |
Page 312 |
Page 313 |
Page 314 |
Page 315 |
Page 316 |
Page 317 |
Page 318 |
Page 319 |
Page 320 |
Page 321 |
Page 322 |
Page 323 |
Page 324 |
Page 325 |
Page 326 |
Page 327 |
Page 328 |
Page 329 |
Page 330 |
Page 331 |
Page 332 |
Page 333 |
Page 334 |
Page 335 |
Page 336 |
Page 337 |
Page 338 |
Page 339 |
Page 340 |
Page 341 |
Page 342 |
Page 343 |
Page 344 |
Page 345 |
Page 346 |
Page 347 |
Page 348 |
Page 349 |
Page 350 |
Page 351 |
Page 352 |
Page 353 |
Page 354 |
Page 355 |
Page 356 |
Page 357 |
Page 358 |
Page 359 |
Page 360 |
Page 361 |
Page 362 |
Page 363 |
Page 364 |
Page 365 |
Page 366 |
Page 367 |
Page 368 |
Page 369 |
Page 370 |
Page 371 |
Page 372 |
Page 373 |
Page 374 |
Page 375 |
Page 376 |
Page 377 |
Page 378 |
Page 379 |
Page 380 |
Page 381 |
Page 382 |
Page 383 |
Page 384 |
Page 385 |
Page 386 |
Page 387 |
Page 388 |
Page 389 |
Page 390 |
Page 391 |
Page 392 |
Page 393 |
Page 394 |
Page 395 |
Page 396 |
Page 397 |
Page 398 |
Page 399 |
Page 400 |
Page 401 |
Page 402 |
Page 403 |
Page 404 |
Page 405 |
Page 406 |
Page 407 |
Page 408 |
Page 409 |
Page 410 |
Page 411 |
Page 412 |
Page 413 |
Page 414 |
Page 415 |
Page 416 |
Page 417 |
Page 418 |
Page 419 |
Page 420 |
Page 421 |
Page 422 |
Page 423 |
Page 424 |
Page 425 |
Page 426 |
Page 427 |
Page 428 |
Page 429 |
Page 430 |
Page 431 |
Page 432 |
Page 433 |
Page 434 |
Page 435 |
Page 436 |
Page 437 |
Page 438 |
Page 439 |
Page 440 |
Page 441 |
Page 442 |
Page 443 |
Page 444 |
Page 445 |
Page 446 |
Page 447 |
Page 448 |
Page 449 |
Page 450 |
Page 451 |
Page 452 |
Page 453 |
Page 454 |
Page 455 |
Page 456 |
Page 457 |
Page 458 |
Page 459 |
Page 460 |
Page 461 |
Page 462 |
Page 463 |
Page 464 |
Page 465 |
Page 466 |
Page 467 |
Page 468 |
Page 469 |
Page 470 |
Page 471 |
Page 472 |
Page 473 |
Page 474 |
Page 475 |
Page 476 |
Page 477 |
Page 478 |
Page 479 |
Page 480 |
Page 481 |
Page 482 |
Page 483 |
Page 484 |
Page 485 |
Page 486 |
Page 487 |
Page 488 |
Page 489 |
Page 490 |
Page 491 |
Page 492 |
Page 493 |
Page 494 |
Page 495 |
Page 496 |
Page 497 |
Page 498 |
Page 499 |
Page 500 |
Page 501 |
Page 502 |
Page 503 |
Page 504 |
Page 505 |
Page 506 |
Page 507 |
Page 508 |
Page 509 |
Page 510 |
Page 511 |
Page 512